Daewoong Pharma (069620) — Capital Reinvestment Ratio

Latest as of September 2025: 1.26x

Daewoong Pharma (069620) has a Capital Reinvestment Ratio of 1.26x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩57.53 Billion) in capital expenditures (₩72.21 Billion). Check 069620 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.26x
Capex / Operating Cash Flow

Operating Cash Flow

₩57.53 Billion
KRW

Capital Expenditures

₩72.21 Billion
KRW

Data as of

Sep 2025
Most recent filing

Daewoong Pharma Capital Reinvestment Ratio (2007–2024)

This chart tracks Daewoong Pharma's Capital Reinvestment Ratio across 16 annual periods. For the full cash flow conversion analysis, see how efficiently does Daewoong Pharma generate cash.

Annual Capital Reinvestment Ratio for Daewoong Pharma (2007–2024)

Year-by-year Capital Reinvestment Ratio for Daewoong Pharma from 2007 to 2024. See Daewoong Pharma free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 4.45x ₩51.49 Billion ₩229.00 Billion ▲ +396.8%
2023 0.90x ₩132.57 Billion ₩118.67 Billion ▲ +62.2%
2022 0.55x ₩118.21 Billion ₩65.23 Billion ▼ -24.1%
2021 0.73x ₩39.99 Billion ₩29.09 Billion ▲ +177.3%
2020 0.26x ₩100.98 Billion ₩26.49 Billion ▼ -32.3%
2019 0.39x ₩57.60 Billion ₩22.31 Billion ▼ -67.7%
2018 1.20x ₩47.50 Billion ₩56.99 Billion ▲ +80.4%
2017 0.67x ₩103.94 Billion ₩69.12 Billion ▼ -93.7%
2016 10.62x ₩15.38 Billion ₩163.25 Billion ▲ +300.5%
2015 2.65x ₩35.89 Billion ₩95.13 Billion ▲ +49.5%
2014 1.77x ₩25.95 Billion ₩46.00 Billion ▲ +404.3%
2013 0.35x ₩54.16 Billion ₩19.04 Billion ▼ -33.4%
2012 0.53x ₩45.02 Billion ₩23.77 Billion ▲ +1.7%
2011 0.52x ₩78.82 Billion ₩40.92 Billion ▼ -54.0%
2008 1.13x ₩31.33 Billion ₩35.35 Billion ▼ -18.8%
2007 1.39x ₩25.81 Billion ₩35.89 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow